•
Jun 30, 2022

Avidity Biosciences Q2 2022 Earnings Report

Total Revenue
$2.18M
Previous year: $2.61M
-16.5%
EPS
-$0.92
Previous year: -$0.7
+31.4%
Gross Profit
-$37.6M
Previous year: -$20.1M
+87.1%
Cash and Equivalents
$125M
Previous year: $276M
-54.7%
Free Cash Flow
-$36.9M
Previous year: -$28.8M
+27.8%
Total Assets
$421M
Previous year: $291M
+44.8%

Avidity Biosciences

Avidity Biosciences